Liquid pharmaceutical formulations of palonosetron
US9457020B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2015 |
| Grant date | Oct 4, 2016 |
| Priority date | — |
| Expiry date | Sep 16, 2035 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65B55/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.